Andrew Proudfoot

Endometriosis and Endocannabinoid System Modulation: optimising cannabinoid medicine in an insurance medicine context for Australian patients

Andrew's project's primary objective will be to examine, survey and understand the current experience and potential barriers to life, disability and trauma insurance access for women with endometriosis managing their disease both with and without cannabis.

The second objective will be to improve the access to life insurance associated financial advice, policy coverage, pricing and contract terms in this patient population across Australia and New Zealand via the development of tools and resources for endometriosis patients and insurer stakeholder groups designed to translationally improve the scientific and health economic understanding of (i) endometriosis and (ii) cannabinoid medicine in an insurance medicine and disease burden context given lack of up-to-date guidance in these areas.


Dr Mike Armour, Dr Sarah Duffy